SBIR grant

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Genalyte a $1 million Small Business Innovation Research grant to develop a biomarker panel to profile tumor antigen-associated antibodies, Genalyte said today.

NEW YORK (GenomeWeb News) – Detroit R&D today announced it has been granted a two-year $1 million Small Business Innovation Research Phase II grant to continue research into protein glycosylation.

NEW YORK (GenomeWeb News) – BioMarker Strategies today announced it is being granted a $1.5 million Small Business Innovation Research Phase II award to further develop its companion diagnostic for melanoma.

NEW YORK (GenomeWeb News) – Adaptive Biotechnologies today said that it has received a $2.53 million Phase II Small Business Innovation Research grant to support its adaptive immune system testing technology.

NEW YORK (GenomeWeb News) – Bioinformatics firm Advaita said this week that it has been awarded up to $2.0 million by the National Institutes of Health to develop software for analyzing next-generation sequencing data for personalized medicine applications.

NEW YORK (GenomeWeb News) – The National Institutes of Health is soliciting applications from small businesses seeking funding under the NIH and Centers for Disease Control and Prevention Small Busine

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute sees rapid point-of-care devices as offering great potential to help advance personalized medicine, and it plans to fund several research projects starting next year to spur development of these tools.

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund small businesses undertaking projects to develop new molecular or cellular analysis tools for use in cancer research and clinical care, according to a new funding announcement.

NEW YORK (GenomeWeb News) – Bioinformatics software firm DNAStar said today it received a Phase II Small Business Innovation Research Grant in support of R&D aimed at expanding the company's sequence assembly and analysis software.

NEW YORK (GenomeWeb News) – Gene modification firm Transposagen Biopharmaceuticals said on Friday that it received $4.3 million in grants and investments to further develop its DNA modification technology.